Actinium-225
Leukemia, prostate, brain, and neuroendocrine tumors
Scale-UpActive
Key Facts
Indication
Leukemia, prostate, brain, and neuroendocrine tumors
Phase
Scale-Up
Status
Active
About NorthStar Medical Technologies
NorthStar Medical Technologies is a pioneering radiopharmaceutical company specializing in the non-uranium, accelerator-based production of therapeutic radioisotopes, notably Ac-225 and Cu-67. Its integrated campus houses the technology, facilities, and expertise to serve as a critical CDMO/CMO, addressing supply chain challenges in the rapidly growing targeted radioligand therapy field. The company is positioned as a near-term commercial-scale producer of these high-demand isotopes, supported by strategic partnerships and a pipeline of development programs aimed at expanding treatment options for various cancers.
View full company profile